2-hydrazinyl-N,N-dimethylaniline | 1314973-15-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-hydrazinyl-N,N-dimethylaniline
• CAS: 1314973-15-3
• 化学式: C₈H₁₃N₃
• mdl: MFCD19202680
• 分子量: 151.211
• InChiKey: UFOIZPRVCWJMCQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  41.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-hydrazinyl-N,N-dimethylaniline 在 盐酸 、 四(三苯基膦)钯 、 sodium carbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 乙醇 、 水 、 甲苯 为溶剂， 反应 2.75h， 生成 2-[5-(4-chlorophenyl)-3-(1-methylsulfonylpiperidin-4-yl)pyrazol-1-yl]-N,N-dimethylaniline
  参考文献：
  名称：

  A novel series of pyrazolylpiperidine N-type calcium channel blockers

  摘要：

  Selective blockers of the N-type calcium channel have proven to be effective in animal models of chronic pain. However, even though intrathecally delivered synthetic x-conotoxin MVIIA from Conus magnus (ziconotide [Prialt (R)]) has been approved for the treatment of chronic pain in humans, its mode of delivery and narrow therapeutic window have limited its usefulness. Therefore, the identification of orally active, small-molecule N-type calcium channel blockers would represent a significant advancement in the treatment of chronic pain. A novel series of pyrazole-based N-type calcium channel blockers was identified by structural modification of a high-throughput screening hit and further optimized to improve potency and metabolic stability. In vivo efficacy in rat models of inflammatory and neuropathic pain was demonstrated by a representative compound from this series. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.04.075

文献信息

• Synthesis of substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles by intramolecular nitrilimine cycloaddition
  作者：Michael P. Winters、Christopher A. Teleha、Zhihua Sui

  DOI：10.1016/j.tetlet.2014.02.068

  日期：2014.3

  Both substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles have been synthesized by the 3+2 intramolecular dipolar cycloaddition of nitrilimines to alkynes. This cyclization has been extended to more versatile 3-bromo derivatives by the use of alkynylbromides as dipolarophiles.

  取代的2,4,5,6-四氢环戊[ c ]吡唑和2,4,5,6-四氢吡咯并[3,4- c ]吡唑是通过亚硝胺的3 + 2分子内偶极环加成反应而合成的。通过使用炔基溴化物作为亲双性体，这种环化作用已扩展为更通用的3-溴衍生物。
• Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel
  作者：Michael P. Winters、Nalin Subasinghe、Mark Wall、Edward Beck、Michael R. Brandt、Michael F.A. Finley、Yi Liu、Mary Lou Lubin、Michael P. Neeper、Ning Qin、Christopher M. Flores、Zhihua Sui

  DOI：10.1016/j.bmcl.2014.03.062

  日期：2014.5

  A novel series of substituted tetrahydropyrrolo[3,4-c]pyrazoles were investigated as blockers of the N-type calcium channel (Cav2.2 channels), a chronic pain target.

  研究了一系列新的取代四氢吡咯并[3,4- c ]吡唑类化合物作为慢性疼痛目标N型钙通道（Ca v 2.2通道）的阻滞剂。
• PYRAZOLOQUINOLONES ARE POTENT PARP INHIBITORS
  申请人：PENNING D. THOMAS

  公开号：US20070249597A1

  公开（公告）日：2007-10-25

  Compounds of Formula (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).

  化合物(I)的公式可以抑制PARP酶，并且可用于治疗与PARP相关的疾病或紊乱。此外，还披露了包含化合物(I)的药物组合物，包括化合物(I)的治疗方法，以及包括化合物(I)的抑制PARP酶的方法。
• Pyrazoloquinolones are potent parp inhibitors
  申请人：Abbott Laboratories

  公开号：EP2468748A1

  公开（公告）日：2012-06-27

  Compounds of Formula (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).

  式(I)化合物抑制PARP酶，可用于治疗与PARP相关的疾病或紊乱。还公开了包含式（I）化合物的药物组合物、包含式（I）化合物的治疗方法以及包含式（I）化合物的抑制 PARP 酶的方法。
• Use of substituted oxadiazoles for combating phytopathogenic fungi
  申请人：BASF SE

  公开号：US10442777B2

  公开（公告）日：2019-10-15

  The present invention relates to the use of novel oxadiazoles of the formula I or an N-oxide and/or their agriculturally useful salts for controlling phytopathogenic fungi, or to a method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula I or an N-oxide or an agriculturally acceptable salt thereof; and to agrochemical compositions comprising at least one such compound and to agrochemical compositions further comprising seeds.

  本发明涉及式 I 的新型噁二唑或其 N-氧化物和/或其农业上有用的盐在控制植物病原真菌方面的用途，或涉及一种防治植物病原有害真菌的方法，该方法包括用有效量的至少一种式 I 的化合物或其 N-氧化物或其农业上可接受的盐处理真菌或待保护的材料、植物、土壤或种子，使其免受真菌侵袭；以及包含至少一种此类化合物的农用化学品组合物和进一步包含种子的农用化学品组合物。